Description: Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company is headquartered in Toronto, Canada.
Home Page: awaknlifesciences.com
301-217 Queen Street West
Toronto,
ON
M5V 0R2
Canada
Phone:
Officers
| Name | Title |
|---|---|
| Mr. Anthony Tennyson | Co-founder, Pres, CEO & Director |
| Dr. Benjamin Sessa B.Sc., MBBS | Co-Founder, Head of Psychedelic Medicine & Member of Clinical Advisory Board |
| Mr. James Collins | Chief Operating Officer |
| Dr. Shaun McNulty Ph.D. | Chief Scientific Officer & Member of Pre-Clinical Advisory Board |
| Mr. George Scorsis | Co-founder & Chairman |
| Mr. Jonathan James Held C.A., CPA, CA | Co-Founder & CFO |
| Mr. Gordo Whittaker | Chief Marketing Officer |
| Prof. David John Nutt DM, FMedSci, FRCP, FRCPsych, FSB, Ph.D. | Chair of Pre-Clinical & Clinical Advisory Board and Chief Research Officer |
| Prof. Celia Morgan | Head of Ketamine-Assisted Therapy & Member of Clinical Advisory Board |
| Dr. Lowan H. Stewart F.A.C.E.P., M.D. | Regional Director of Nordics & MD of Awakn Oslo AS |
Exchange: NEO
Country: CA
Currency: Canadian Dollar (C$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.9086 |
| Price-to-Sales TTM: | 11.5264 |
| IPO Date: | |
| Fiscal Year End: | January |
| Full Time Employees: | 43 |